- call +1-201-465-4211
- email sales@marketquest.biz
- Call +1-201-465-4211
- Email: sales@marketquest.biz
A vaccine is a biological preparation that provides active acquired immunity to a particular disease. A vaccine typically contains an agent that resembles a disease-causing microorganism and is often made from weakened or killed forms of the microbe, its toxins or one of its surface proteins.
According to our latest study, the global Human Vaccine market size was valued at USD 32870 million in 2022 and is forecast to a readjusted size of USD 44570 million by 2029 with a CAGR of 4.4% during review period. The influence of COVID-19 and the Russia-Ukraine War were considered while estimating market sizes.
In China, Human Vaccine key players include CNBG, Kangtai, ChengDa Bio, etc. Global top three manufacturers hold a share about 65%.
East China is the largest market, with a share about 25%, followed by South China, and North China, both have a share about 40 percent.
In terms of product, Hepatitis B is the largest segment, with a share nearly 15%. And in terms of application, the largest application is Children, followed by Adults.
This report is a detailed and comprehensive analysis for global Human Vaccine market. Both quantitative and qualitative analyses are presented by manufacturers, by region & country, by Type and by Application. As the market is constantly changing, this report explores the competition, supply and demand trends, as well as key factors that contribute to its changing demands across many markets. Company profiles and product examples of selected competitors, along with market share estimates of some of the selected leaders for the year 2023, are provided.
Key Features:
Global Human Vaccine market size and forecasts, in consumption value ($ Million), sales quantity (M Doses), and average selling prices (USD/Dose), 2018-2029
Global Human Vaccine market size and forecasts by region and country, in consumption value ($ Million), sales quantity (M Doses), and average selling prices (USD/Dose), 2018-2029
Global Human Vaccine market size and forecasts, by Type and by Application, in consumption value ($ Million), sales quantity (M Doses), and average selling prices (USD/Dose), 2018-2029
Global Human Vaccine market shares of main players, shipments in revenue ($ Million), sales quantity (M Doses), and ASP (USD/Dose), 2018-2023
The Primary Objectives in This Report Are:
To determine the size of the total market opportunity of global and key countries
To assess the growth potential for Human Vaccine
To forecast future growth in each product and end-use market
To assess competitive factors affecting the marketplace
This report profiles key players in the global Human Vaccine market based on the following parameters - company overview, production, value, price, gross margin, product portfolio, geographical presence, and key developments. Key companies covered as a part of this study include CNBG, Changsheng Life, Zhifei, ChengDa Bio and Kangtai, etc.
This report also provides key insights about market drivers, restraints, opportunities, new product launches or approvals, COVID-19 and Russia-Ukraine War Influence.
Market Segmentation
Human Vaccine market is split by Type and by Application. For the period 2018-2029, the growth among segments provides accurate calculations and forecasts for consumption value by Type, and by Application in terms of volume and value. This analysis can help you expand your business by targeting qualified niche markets.
Market segment by Type
Varicella
Influenza
Polio
Hepatitis A
Rabies
BCG
Hepatitis B
Pertussis, Diphtheria, Tetanus
Pneumococcal
Rota vaccine
Market segment by Application
Adults
Children
Major players covered
CNBG
Changsheng Life
Zhifei
ChengDa Bio
Kangtai
SINOVAC BIOTECH
Hissen
Walvax Biotechnology
GSK
SANOFI
Rong An
NuoCheng Bio
Hualan Bio
Tiantan biological
Changchun Baike
Adimmune
Zhongyianke Biotech
Bharat Biotech
Bavarian Nordic
Sanofi-Pasteur
Indian Immunologicals
KANGH
Henan Grand Biopharma
ZhongKe Biopharm
Zhuoyi Biological
Market segment by region, regional analysis covers
North America (United States, Canada and Mexico)
Europe (Germany, France, United Kingdom, Russia, Italy, and Rest of Europe)
Asia-Pacific (China, Japan, Korea, India, Southeast Asia, and Australia)
South America (Brazil, Argentina, Colombia, and Rest of South America)
Middle East & Africa (Saudi Arabia, UAE, Egypt, South Africa, and Rest of Middle East & Africa)
The content of the study subjects, includes a total of 15 chapters:
Chapter 1, to describe Human Vaccine product scope, market overview, market estimation caveats and base year.
Chapter 2, to profile the top manufacturers of Human Vaccine, with price, sales, revenue and global market share of Human Vaccine from 2018 to 2023.
Chapter 3, the Human Vaccine competitive situation, sales quantity, revenue and global market share of top manufacturers are analyzed emphatically by landscape contrast.
Chapter 4, the Human Vaccine breakdown data are shown at the regional level, to show the sales quantity, consumption value and growth by regions, from 2018 to 2029.
Chapter 5 and 6, to segment the sales by Type and application, with sales market share and growth rate by type, application, from 2018 to 2029.
Chapter 7, 8, 9, 10 and 11, to break the sales data at the country level, with sales quantity, consumption value and market share for key countries in the world, from 2017 to 2022.and Human Vaccine market forecast, by regions, type and application, with sales and revenue, from 2024 to 2029.
Chapter 12, market dynamics, drivers, restraints, trends, Porters Five Forces analysis, and Influence of COVID-19 and Russia-Ukraine War.
Chapter 13, the key raw materials and key suppliers, and industry chain of Human Vaccine.
Chapter 14 and 15, to describe Human Vaccine sales channel, distributors, customers, research findings and conclusion.
The base year for the study has been considered 2019, historic year 2014 and 2018, the forecast period considered is from 2020 to 2027. The regions analyzed for the market include North America, Europe, South America, Asia Pacific, and Middle East and Africa. These regions are further analyzed at the country-level. The study also includes attractiveness analysis of type, application and regions which are benchmarked based on their market size, growth rate and attractiveness in terms of present and future opportunity for understanding the future growth of the market.
Market is segmented on the basis:
The report offers in-depth analysis of driving factors, opportunities, restraints, and challenges for gaining the key insight of the market. The report emphasizes on all the key trends that play a vital role in the enlargement of the market from 2019 to 2026.
The report provides company profile of the key players operating in the market and a comparative analysis based on their business overviews industry offering, segment market share, regional presence, business strategies, innovations, mergers & acquisitions, recent developments, joint venture, collaborations, partnerships, SWOT analysis, and key financial information.
1 Market Overview
1.1 Product Overview and Scope of Human Vaccine
1.2 Market Estimation Caveats and Base Year
1.3 Market Analysis by Type
1.3.1 Overview: Global Human Vaccine Consumption Value by Type: 2018 Versus 2022 Versus 2029
1.3.2 Varicella
1.3.3 Influenza
1.3.4 Polio
1.3.5 Hepatitis A
1.3.6 Rabies
1.3.7 BCG
1.3.8 Hepatitis B
1.3.9 Pertussis, Diphtheria, Tetanus
1.3.10 Pneumococcal
1.3.11 Rota vaccine
1.4 Market Analysis by Application
1.4.1 Overview: Global Human Vaccine Consumption Value by Application: 2018 Versus 2022 Versus 2029
1.4.2 Adults
1.4.3 Children
1.5 Global Human Vaccine Market Size & Forecast
1.5.1 Global Human Vaccine Consumption Value (2018 & 2022 & 2029)
1.5.2 Global Human Vaccine Sales Quantity (2018-2029)
1.5.3 Global Human Vaccine Average Price (2018-2029)
2 Manufacturers Profiles
2.1 CNBG
2.1.1 CNBG Details
2.1.2 CNBG Major Business
2.1.3 CNBG Human Vaccine Product and Services
2.1.4 CNBG Human Vaccine Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.1.5 CNBG Recent Developments/Updates
2.2 Changsheng Life
2.2.1 Changsheng Life Details
2.2.2 Changsheng Life Major Business
2.2.3 Changsheng Life Human Vaccine Product and Services
2.2.4 Changsheng Life Human Vaccine Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.2.5 Changsheng Life Recent Developments/Updates
2.3 Zhifei
2.3.1 Zhifei Details
2.3.2 Zhifei Major Business
2.3.3 Zhifei Human Vaccine Product and Services
2.3.4 Zhifei Human Vaccine Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.3.5 Zhifei Recent Developments/Updates
2.4 ChengDa Bio
2.4.1 ChengDa Bio Details
2.4.2 ChengDa Bio Major Business
2.4.3 ChengDa Bio Human Vaccine Product and Services
2.4.4 ChengDa Bio Human Vaccine Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.4.5 ChengDa Bio Recent Developments/Updates
2.5 Kangtai
2.5.1 Kangtai Details
2.5.2 Kangtai Major Business
2.5.3 Kangtai Human Vaccine Product and Services
2.5.4 Kangtai Human Vaccine Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.5.5 Kangtai Recent Developments/Updates
2.6 SINOVAC BIOTECH
2.6.1 SINOVAC BIOTECH Details
2.6.2 SINOVAC BIOTECH Major Business
2.6.3 SINOVAC BIOTECH Human Vaccine Product and Services
2.6.4 SINOVAC BIOTECH Human Vaccine Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.6.5 SINOVAC BIOTECH Recent Developments/Updates
2.7 Hissen
2.7.1 Hissen Details
2.7.2 Hissen Major Business
2.7.3 Hissen Human Vaccine Product and Services
2.7.4 Hissen Human Vaccine Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.7.5 Hissen Recent Developments/Updates
2.8 Walvax Biotechnology
2.8.1 Walvax Biotechnology Details
2.8.2 Walvax Biotechnology Major Business
2.8.3 Walvax Biotechnology Human Vaccine Product and Services
2.8.4 Walvax Biotechnology Human Vaccine Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.8.5 Walvax Biotechnology Recent Developments/Updates
2.9 GSK
2.9.1 GSK Details
2.9.2 GSK Major Business
2.9.3 GSK Human Vaccine Product and Services
2.9.4 GSK Human Vaccine Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.9.5 GSK Recent Developments/Updates
2.10 SANOFI
2.10.1 SANOFI Details
2.10.2 SANOFI Major Business
2.10.3 SANOFI Human Vaccine Product and Services
2.10.4 SANOFI Human Vaccine Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.10.5 SANOFI Recent Developments/Updates
2.11 Rong An
2.11.1 Rong An Details
2.11.2 Rong An Major Business
2.11.3 Rong An Human Vaccine Product and Services
2.11.4 Rong An Human Vaccine Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.11.5 Rong An Recent Developments/Updates
2.12 NuoCheng Bio
2.12.1 NuoCheng Bio Details
2.12.2 NuoCheng Bio Major Business
2.12.3 NuoCheng Bio Human Vaccine Product and Services
2.12.4 NuoCheng Bio Human Vaccine Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.12.5 NuoCheng Bio Recent Developments/Updates
2.13 Hualan Bio
2.13.1 Hualan Bio Details
2.13.2 Hualan Bio Major Business
2.13.3 Hualan Bio Human Vaccine Product and Services
2.13.4 Hualan Bio Human Vaccine Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.13.5 Hualan Bio Recent Developments/Updates
2.14 Tiantan biological
2.14.1 Tiantan biological Details
2.14.2 Tiantan biological Major Business
2.14.3 Tiantan biological Human Vaccine Product and Services
2.14.4 Tiantan biological Human Vaccine Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.14.5 Tiantan biological Recent Developments/Updates
2.15 Changchun Baike
2.15.1 Changchun Baike Details
2.15.2 Changchun Baike Major Business
2.15.3 Changchun Baike Human Vaccine Product and Services
2.15.4 Changchun Baike Human Vaccine Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.15.5 Changchun Baike Recent Developments/Updates
2.16 Adimmune
2.16.1 Adimmune Details
2.16.2 Adimmune Major Business
2.16.3 Adimmune Human Vaccine Product and Services
2.16.4 Adimmune Human Vaccine Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.16.5 Adimmune Recent Developments/Updates
2.17 Zhongyianke Biotech
2.17.1 Zhongyianke Biotech Details
2.17.2 Zhongyianke Biotech Major Business
2.17.3 Zhongyianke Biotech Human Vaccine Product and Services
2.17.4 Zhongyianke Biotech Human Vaccine Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.17.5 Zhongyianke Biotech Recent Developments/Updates
2.18 Bharat Biotech
2.18.1 Bharat Biotech Details
2.18.2 Bharat Biotech Major Business
2.18.3 Bharat Biotech Human Vaccine Product and Services
2.18.4 Bharat Biotech Human Vaccine Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.18.5 Bharat Biotech Recent Developments/Updates
2.19 Bavarian Nordic
2.19.1 Bavarian Nordic Details
2.19.2 Bavarian Nordic Major Business
2.19.3 Bavarian Nordic Human Vaccine Product and Services
2.19.4 Bavarian Nordic Human Vaccine Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.19.5 Bavarian Nordic Recent Developments/Updates
2.20 Sanofi-Pasteur
2.20.1 Sanofi-Pasteur Details
2.20.2 Sanofi-Pasteur Major Business
2.20.3 Sanofi-Pasteur Human Vaccine Product and Services
2.20.4 Sanofi-Pasteur Human Vaccine Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.20.5 Sanofi-Pasteur Recent Developments/Updates
2.21 Indian Immunologicals
2.21.1 Indian Immunologicals Details
2.21.2 Indian Immunologicals Major Business
2.21.3 Indian Immunologicals Human Vaccine Product and Services
2.21.4 Indian Immunologicals Human Vaccine Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.21.5 Indian Immunologicals Recent Developments/Updates
2.22 KANGH
2.22.1 KANGH Details
2.22.2 KANGH Major Business
2.22.3 KANGH Human Vaccine Product and Services
2.22.4 KANGH Human Vaccine Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.22.5 KANGH Recent Developments/Updates
2.23 Henan Grand Biopharma
2.23.1 Henan Grand Biopharma Details
2.23.2 Henan Grand Biopharma Major Business
2.23.3 Henan Grand Biopharma Human Vaccine Product and Services
2.23.4 Henan Grand Biopharma Human Vaccine Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.23.5 Henan Grand Biopharma Recent Developments/Updates
2.24 ZhongKe Biopharm
2.24.1 ZhongKe Biopharm Details
2.24.2 ZhongKe Biopharm Major Business
2.24.3 ZhongKe Biopharm Human Vaccine Product and Services
2.24.4 ZhongKe Biopharm Human Vaccine Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.24.5 ZhongKe Biopharm Recent Developments/Updates
2.25 Zhuoyi Biological
2.25.1 Zhuoyi Biological Details
2.25.2 Zhuoyi Biological Major Business
2.25.3 Zhuoyi Biological Human Vaccine Product and Services
2.25.4 Zhuoyi Biological Human Vaccine Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.25.5 Zhuoyi Biological Recent Developments/Updates
3 Competitive Environment: Human Vaccine by Manufacturer
3.1 Global Human Vaccine Sales Quantity by Manufacturer (2018-2023)
3.2 Global Human Vaccine Revenue by Manufacturer (2018-2023)
3.3 Global Human Vaccine Average Price by Manufacturer (2018-2023)
3.4 Market Share Analysis (2022)
3.4.1 Producer Shipments of Human Vaccine by Manufacturer Revenue ($MM) and Market Share (%): 2022
3.4.2 Top 3 Human Vaccine Manufacturer Market Share in 2022
3.4.2 Top 6 Human Vaccine Manufacturer Market Share in 2022
3.5 Human Vaccine Market: Overall Company Footprint Analysis
3.5.1 Human Vaccine Market: Region Footprint
3.5.2 Human Vaccine Market: Company Product Type Footprint
3.5.3 Human Vaccine Market: Company Product Application Footprint
3.6 New Market Entrants and Barriers to Market Entry
3.7 Mergers, Acquisition, Agreements, and Collaborations
4 Consumption Analysis by Region
4.1 Global Human Vaccine Market Size by Region
4.1.1 Global Human Vaccine Sales Quantity by Region (2018-2029)
4.1.2 Global Human Vaccine Consumption Value by Region (2018-2029)
4.1.3 Global Human Vaccine Average Price by Region (2018-2029)
4.2 North America Human Vaccine Consumption Value (2018-2029)
4.3 Europe Human Vaccine Consumption Value (2018-2029)
4.4 Asia-Pacific Human Vaccine Consumption Value (2018-2029)
4.5 South America Human Vaccine Consumption Value (2018-2029)
4.6 Middle East and Africa Human Vaccine Consumption Value (2018-2029)
5 Market Segment by Type
5.1 Global Human Vaccine Sales Quantity by Type (2018-2029)
5.2 Global Human Vaccine Consumption Value by Type (2018-2029)
5.3 Global Human Vaccine Average Price by Type (2018-2029)
6 Market Segment by Application
6.1 Global Human Vaccine Sales Quantity by Application (2018-2029)
6.2 Global Human Vaccine Consumption Value by Application (2018-2029)
6.3 Global Human Vaccine Average Price by Application (2018-2029)
7 North America
7.1 North America Human Vaccine Sales Quantity by Type (2018-2029)
7.2 North America Human Vaccine Sales Quantity by Application (2018-2029)
7.3 North America Human Vaccine Market Size by Country
7.3.1 North America Human Vaccine Sales Quantity by Country (2018-2029)
7.3.2 North America Human Vaccine Consumption Value by Country (2018-2029)
7.3.3 United States Market Size and Forecast (2018-2029)
7.3.4 Canada Market Size and Forecast (2018-2029)
7.3.5 Mexico Market Size and Forecast (2018-2029)
8 Europe
8.1 Europe Human Vaccine Sales Quantity by Type (2018-2029)
8.2 Europe Human Vaccine Sales Quantity by Application (2018-2029)
8.3 Europe Human Vaccine Market Size by Country
8.3.1 Europe Human Vaccine Sales Quantity by Country (2018-2029)
8.3.2 Europe Human Vaccine Consumption Value by Country (2018-2029)
8.3.3 Germany Market Size and Forecast (2018-2029)
8.3.4 France Market Size and Forecast (2018-2029)
8.3.5 United Kingdom Market Size and Forecast (2018-2029)
8.3.6 Russia Market Size and Forecast (2018-2029)
8.3.7 Italy Market Size and Forecast (2018-2029)
9 Asia-Pacific
9.1 Asia-Pacific Human Vaccine Sales Quantity by Type (2018-2029)
9.2 Asia-Pacific Human Vaccine Sales Quantity by Application (2018-2029)
9.3 Asia-Pacific Human Vaccine Market Size by Region
9.3.1 Asia-Pacific Human Vaccine Sales Quantity by Region (2018-2029)
9.3.2 Asia-Pacific Human Vaccine Consumption Value by Region (2018-2029)
9.3.3 China Market Size and Forecast (2018-2029)
9.3.4 Japan Market Size and Forecast (2018-2029)
9.3.5 Korea Market Size and Forecast (2018-2029)
9.3.6 India Market Size and Forecast (2018-2029)
9.3.7 Southeast Asia Market Size and Forecast (2018-2029)
9.3.8 Australia Market Size and Forecast (2018-2029)
10 South America
10.1 South America Human Vaccine Sales Quantity by Type (2018-2029)
10.2 South America Human Vaccine Sales Quantity by Application (2018-2029)
10.3 South America Human Vaccine Market Size by Country
10.3.1 South America Human Vaccine Sales Quantity by Country (2018-2029)
10.3.2 South America Human Vaccine Consumption Value by Country (2018-2029)
10.3.3 Brazil Market Size and Forecast (2018-2029)
10.3.4 Argentina Market Size and Forecast (2018-2029)
11 Middle East & Africa
11.1 Middle East & Africa Human Vaccine Sales Quantity by Type (2018-2029)
11.2 Middle East & Africa Human Vaccine Sales Quantity by Application (2018-2029)
11.3 Middle East & Africa Human Vaccine Market Size by Country
11.3.1 Middle East & Africa Human Vaccine Sales Quantity by Country (2018-2029)
11.3.2 Middle East & Africa Human Vaccine Consumption Value by Country (2018-2029)
11.3.3 Turkey Market Size and Forecast (2018-2029)
11.3.4 Egypt Market Size and Forecast (2018-2029)
11.3.5 Saudi Arabia Market Size and Forecast (2018-2029)
11.3.6 South Africa Market Size and Forecast (2018-2029)
12 Market Dynamics
12.1 Human Vaccine Market Drivers
12.2 Human Vaccine Market Restraints
12.3 Human Vaccine Trends Analysis
12.4 Porters Five Forces Analysis
12.4.1 Threat of New Entrants
12.4.2 Bargaining Power of Suppliers
12.4.3 Bargaining Power of Buyers
12.4.4 Threat of Substitutes
12.4.5 Competitive Rivalry
12.5 Influence of COVID-19 and Russia-Ukraine War
12.5.1 Influence of COVID-19
12.5.2 Influence of Russia-Ukraine War
13 Raw Material and Industry Chain
13.1 Raw Material of Human Vaccine and Key Manufacturers
13.2 Manufacturing Costs Percentage of Human Vaccine
13.3 Human Vaccine Production Process
13.4 Human Vaccine Industrial Chain
14 Shipments by Distribution Channel
14.1 Sales Channel
14.1.1 Direct to End-User
14.1.2 Distributors
14.2 Human Vaccine Typical Distributors
14.3 Human Vaccine Typical Customers
15 Research Findings and Conclusion
16 Appendix
16.1 Methodology
16.2 Research Process and Data Source
16.3 Disclaimer
List of Tables
Table 1. Global Human Vaccine Consumption Value by Type, (USD Million), 2018 & 2022 & 2029
Table 2. Global Human Vaccine Consumption Value by Application, (USD Million), 2018 & 2022 & 2029
Table 3. CNBG Basic Information, Manufacturing Base and Competitors
Table 4. CNBG Major Business
Table 5. CNBG Human Vaccine Product and Services
Table 6. CNBG Human Vaccine Sales Quantity (M Doses), Average Price (USD/Dose), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 7. CNBG Recent Developments/Updates
Table 8. Changsheng Life Basic Information, Manufacturing Base and Competitors
Table 9. Changsheng Life Major Business
Table 10. Changsheng Life Human Vaccine Product and Services
Table 11. Changsheng Life Human Vaccine Sales Quantity (M Doses), Average Price (USD/Dose), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 12. Changsheng Life Recent Developments/Updates
Table 13. Zhifei Basic Information, Manufacturing Base and Competitors
Table 14. Zhifei Major Business
Table 15. Zhifei Human Vaccine Product and Services
Table 16. Zhifei Human Vaccine Sales Quantity (M Doses), Average Price (USD/Dose), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 17. Zhifei Recent Developments/Updates
Table 18. ChengDa Bio Basic Information, Manufacturing Base and Competitors
Table 19. ChengDa Bio Major Business
Table 20. ChengDa Bio Human Vaccine Product and Services
Table 21. ChengDa Bio Human Vaccine Sales Quantity (M Doses), Average Price (USD/Dose), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 22. ChengDa Bio Recent Developments/Updates
Table 23. Kangtai Basic Information, Manufacturing Base and Competitors
Table 24. Kangtai Major Business
Table 25. Kangtai Human Vaccine Product and Services
Table 26. Kangtai Human Vaccine Sales Quantity (M Doses), Average Price (USD/Dose), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 27. Kangtai Recent Developments/Updates
Table 28. SINOVAC BIOTECH Basic Information, Manufacturing Base and Competitors
Table 29. SINOVAC BIOTECH Major Business
Table 30. SINOVAC BIOTECH Human Vaccine Product and Services
Table 31. SINOVAC BIOTECH Human Vaccine Sales Quantity (M Doses), Average Price (USD/Dose), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 32. SINOVAC BIOTECH Recent Developments/Updates
Table 33. Hissen Basic Information, Manufacturing Base and Competitors
Table 34. Hissen Major Business
Table 35. Hissen Human Vaccine Product and Services
Table 36. Hissen Human Vaccine Sales Quantity (M Doses), Average Price (USD/Dose), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 37. Hissen Recent Developments/Updates
Table 38. Walvax Biotechnology Basic Information, Manufacturing Base and Competitors
Table 39. Walvax Biotechnology Major Business
Table 40. Walvax Biotechnology Human Vaccine Product and Services
Table 41. Walvax Biotechnology Human Vaccine Sales Quantity (M Doses), Average Price (USD/Dose), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 42. Walvax Biotechnology Recent Developments/Updates
Table 43. GSK Basic Information, Manufacturing Base and Competitors
Table 44. GSK Major Business
Table 45. GSK Human Vaccine Product and Services
Table 46. GSK Human Vaccine Sales Quantity (M Doses), Average Price (USD/Dose), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 47. GSK Recent Developments/Updates
Table 48. SANOFI Basic Information, Manufacturing Base and Competitors
Table 49. SANOFI Major Business
Table 50. SANOFI Human Vaccine Product and Services
Table 51. SANOFI Human Vaccine Sales Quantity (M Doses), Average Price (USD/Dose), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 52. SANOFI Recent Developments/Updates
Table 53. Rong An Basic Information, Manufacturing Base and Competitors
Table 54. Rong An Major Business
Table 55. Rong An Human Vaccine Product and Services
Table 56. Rong An Human Vaccine Sales Quantity (M Doses), Average Price (USD/Dose), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 57. Rong An Recent Developments/Updates
Table 58. NuoCheng Bio Basic Information, Manufacturing Base and Competitors
Table 59. NuoCheng Bio Major Business
Table 60. NuoCheng Bio Human Vaccine Product and Services
Table 61. NuoCheng Bio Human Vaccine Sales Quantity (M Doses), Average Price (USD/Dose), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 62. NuoCheng Bio Recent Developments/Updates
Table 63. Hualan Bio Basic Information, Manufacturing Base and Competitors
Table 64. Hualan Bio Major Business
Table 65. Hualan Bio Human Vaccine Product and Services
Table 66. Hualan Bio Human Vaccine Sales Quantity (M Doses), Average Price (USD/Dose), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 67. Hualan Bio Recent Developments/Updates
Table 68. Tiantan biological Basic Information, Manufacturing Base and Competitors
Table 69. Tiantan biological Major Business
Table 70. Tiantan biological Human Vaccine Product and Services
Table 71. Tiantan biological Human Vaccine Sales Quantity (M Doses), Average Price (USD/Dose), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 72. Tiantan biological Recent Developments/Updates
Table 73. Changchun Baike Basic Information, Manufacturing Base and Competitors
Table 74. Changchun Baike Major Business
Table 75. Changchun Baike Human Vaccine Product and Services
Table 76. Changchun Baike Human Vaccine Sales Quantity (M Doses), Average Price (USD/Dose), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 77. Changchun Baike Recent Developments/Updates
Table 78. Adimmune Basic Information, Manufacturing Base and Competitors
Table 79. Adimmune Major Business
Table 80. Adimmune Human Vaccine Product and Services
Table 81. Adimmune Human Vaccine Sales Quantity (M Doses), Average Price (USD/Dose), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 82. Adimmune Recent Developments/Updates
Table 83. Zhongyianke Biotech Basic Information, Manufacturing Base and Competitors
Table 84. Zhongyianke Biotech Major Business
Table 85. Zhongyianke Biotech Human Vaccine Product and Services
Table 86. Zhongyianke Biotech Human Vaccine Sales Quantity (M Doses), Average Price (USD/Dose), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 87. Zhongyianke Biotech Recent Developments/Updates
Table 88. Bharat Biotech Basic Information, Manufacturing Base and Competitors
Table 89. Bharat Biotech Major Business
Table 90. Bharat Biotech Human Vaccine Product and Services
Table 91. Bharat Biotech Human Vaccine Sales Quantity (M Doses), Average Price (USD/Dose), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 92. Bharat Biotech Recent Developments/Updates
Table 93. Bavarian Nordic Basic Information, Manufacturing Base and Competitors
Table 94. Bavarian Nordic Major Business
Table 95. Bavarian Nordic Human Vaccine Product and Services
Table 96. Bavarian Nordic Human Vaccine Sales Quantity (M Doses), Average Price (USD/Dose), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 97. Bavarian Nordic Recent Developments/Updates
Table 98. Sanofi-Pasteur Basic Information, Manufacturing Base and Competitors
Table 99. Sanofi-Pasteur Major Business
Table 100. Sanofi-Pasteur Human Vaccine Product and Services
Table 101. Sanofi-Pasteur Human Vaccine Sales Quantity (M Doses), Average Price (USD/Dose), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 102. Sanofi-Pasteur Recent Developments/Updates
Table 103. Indian Immunologicals Basic Information, Manufacturing Base and Competitors
Table 104. Indian Immunologicals Major Business
Table 105. Indian Immunologicals Human Vaccine Product and Services
Table 106. Indian Immunologicals Human Vaccine Sales Quantity (M Doses), Average Price (USD/Dose), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 107. Indian Immunologicals Recent Developments/Updates
Table 108. KANGH Basic Information, Manufacturing Base and Competitors
Table 109. KANGH Major Business
Table 110. KANGH Human Vaccine Product and Services
Table 111. KANGH Human Vaccine Sales Quantity (M Doses), Average Price (USD/Dose), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 112. KANGH Recent Developments/Updates
Table 113. Henan Grand Biopharma Basic Information, Manufacturing Base and Competitors
Table 114. Henan Grand Biopharma Major Business
Table 115. Henan Grand Biopharma Human Vaccine Product and Services
Table 116. Henan Grand Biopharma Human Vaccine Sales Quantity (M Doses), Average Price (USD/Dose), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 117. Henan Grand Biopharma Recent Developments/Updates
Table 118. ZhongKe Biopharm Basic Information, Manufacturing Base and Competitors
Table 119. ZhongKe Biopharm Major Business
Table 120. ZhongKe Biopharm Human Vaccine Product and Services
Table 121. ZhongKe Biopharm Human Vaccine Sales Quantity (M Doses), Average Price (USD/Dose), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 122. ZhongKe Biopharm Recent Developments/Updates
Table 123. Zhuoyi Biological Basic Information, Manufacturing Base and Competitors
Table 124. Zhuoyi Biological Major Business
Table 125. Zhuoyi Biological Human Vaccine Product and Services
Table 126. Zhuoyi Biological Human Vaccine Sales Quantity (M Doses), Average Price (USD/Dose), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 127. Zhuoyi Biological Recent Developments/Updates
Table 128. Global Human Vaccine Sales Quantity by Manufacturer (2018-2023) & (M Doses)
Table 129. Global Human Vaccine Revenue by Manufacturer (2018-2023) & (USD Million)
Table 130. Global Human Vaccine Average Price by Manufacturer (2018-2023) & (USD/Dose)
Table 131. Market Position of Manufacturers in Human Vaccine, (Tier 1, Tier 2, and Tier 3), Based on Consumption Value in 2022
Table 132. Head Office and Human Vaccine Production Site of Key Manufacturer
Table 133. Human Vaccine Market: Company Product Type Footprint
Table 134. Human Vaccine Market: Company Product Application Footprint
Table 135. Human Vaccine New Market Entrants and Barriers to Market Entry
Table 136. Human Vaccine Mergers, Acquisition, Agreements, and Collaborations
Table 137. Global Human Vaccine Sales Quantity by Region (2018-2023) & (M Doses)
Table 138. Global Human Vaccine Sales Quantity by Region (2024-2029) & (M Doses)
Table 139. Global Human Vaccine Consumption Value by Region (2018-2023) & (USD Million)
Table 140. Global Human Vaccine Consumption Value by Region (2024-2029) & (USD Million)
Table 141. Global Human Vaccine Average Price by Region (2018-2023) & (USD/Dose)
Table 142. Global Human Vaccine Average Price by Region (2024-2029) & (USD/Dose)
Table 143. Global Human Vaccine Sales Quantity by Type (2018-2023) & (M Doses)
Table 144. Global Human Vaccine Sales Quantity by Type (2024-2029) & (M Doses)
Table 145. Global Human Vaccine Consumption Value by Type (2018-2023) & (USD Million)
Table 146. Global Human Vaccine Consumption Value by Type (2024-2029) & (USD Million)
Table 147. Global Human Vaccine Average Price by Type (2018-2023) & (USD/Dose)
Table 148. Global Human Vaccine Average Price by Type (2024-2029) & (USD/Dose)
Table 149. Global Human Vaccine Sales Quantity by Application (2018-2023) & (M Doses)
Table 150. Global Human Vaccine Sales Quantity by Application (2024-2029) & (M Doses)
Table 151. Global Human Vaccine Consumption Value by Application (2018-2023) & (USD Million)
Table 152. Global Human Vaccine Consumption Value by Application (2024-2029) & (USD Million)
Table 153. Global Human Vaccine Average Price by Application (2018-2023) & (USD/Dose)
Table 154. Global Human Vaccine Average Price by Application (2024-2029) & (USD/Dose)
Table 155. North America Human Vaccine Sales Quantity by Type (2018-2023) & (M Doses)
Table 156. North America Human Vaccine Sales Quantity by Type (2024-2029) & (M Doses)
Table 157. North America Human Vaccine Sales Quantity by Application (2018-2023) & (M Doses)
Table 158. North America Human Vaccine Sales Quantity by Application (2024-2029) & (M Doses)
Table 159. North America Human Vaccine Sales Quantity by Country (2018-2023) & (M Doses)
Table 160. North America Human Vaccine Sales Quantity by Country (2024-2029) & (M Doses)
Table 161. North America Human Vaccine Consumption Value by Country (2018-2023) & (USD Million)
Table 162. North America Human Vaccine Consumption Value by Country (2024-2029) & (USD Million)
Table 163. Europe Human Vaccine Sales Quantity by Type (2018-2023) & (M Doses)
Table 164. Europe Human Vaccine Sales Quantity by Type (2024-2029) & (M Doses)
Table 165. Europe Human Vaccine Sales Quantity by Application (2018-2023) & (M Doses)
Table 166. Europe Human Vaccine Sales Quantity by Application (2024-2029) & (M Doses)
Table 167. Europe Human Vaccine Sales Quantity by Country (2018-2023) & (M Doses)
Table 168. Europe Human Vaccine Sales Quantity by Country (2024-2029) & (M Doses)
Table 169. Europe Human Vaccine Consumption Value by Country (2018-2023) & (USD Million)
Table 170. Europe Human Vaccine Consumption Value by Country (2024-2029) & (USD Million)
Table 171. Asia-Pacific Human Vaccine Sales Quantity by Type (2018-2023) & (M Doses)
Table 172. Asia-Pacific Human Vaccine Sales Quantity by Type (2024-2029) & (M Doses)
Table 173. Asia-Pacific Human Vaccine Sales Quantity by Application (2018-2023) & (M Doses)
Table 174. Asia-Pacific Human Vaccine Sales Quantity by Application (2024-2029) & (M Doses)
Table 175. Asia-Pacific Human Vaccine Sales Quantity by Region (2018-2023) & (M Doses)
Table 176. Asia-Pacific Human Vaccine Sales Quantity by Region (2024-2029) & (M Doses)
Table 177. Asia-Pacific Human Vaccine Consumption Value by Region (2018-2023) & (USD Million)
Table 178. Asia-Pacific Human Vaccine Consumption Value by Region (2024-2029) & (USD Million)
Table 179. South America Human Vaccine Sales Quantity by Type (2018-2023) & (M Doses)
Table 180. South America Human Vaccine Sales Quantity by Type (2024-2029) & (M Doses)
Table 181. South America Human Vaccine Sales Quantity by Application (2018-2023) & (M Doses)
Table 182. South America Human Vaccine Sales Quantity by Application (2024-2029) & (M Doses)
Table 183. South America Human Vaccine Sales Quantity by Country (2018-2023) & (M Doses)
Table 184. South America Human Vaccine Sales Quantity by Country (2024-2029) & (M Doses)
Table 185. South America Human Vaccine Consumption Value by Country (2018-2023) & (USD Million)
Table 186. South America Human Vaccine Consumption Value by Country (2024-2029) & (USD Million)
Table 187. Middle East & Africa Human Vaccine Sales Quantity by Type (2018-2023) & (M Doses)
Table 188. Middle East & Africa Human Vaccine Sales Quantity by Type (2024-2029) & (M Doses)
Table 189. Middle East & Africa Human Vaccine Sales Quantity by Application (2018-2023) & (M Doses)
Table 190. Middle East & Africa Human Vaccine Sales Quantity by Application (2024-2029) & (M Doses)
Table 191. Middle East & Africa Human Vaccine Sales Quantity by Region (2018-2023) & (M Doses)
Table 192. Middle East & Africa Human Vaccine Sales Quantity by Region (2024-2029) & (M Doses)
Table 193. Middle East & Africa Human Vaccine Consumption Value by Region (2018-2023) & (USD Million)
Table 194. Middle East & Africa Human Vaccine Consumption Value by Region (2024-2029) & (USD Million)
Table 195. Human Vaccine Raw Material
Table 196. Key Manufacturers of Human Vaccine Raw Materials
Table 197. Human Vaccine Typical Distributors
Table 198. Human Vaccine Typical Customers
List of Figures
Figure 1. Human Vaccine Picture
Figure 2. Global Human Vaccine Consumption Value by Type, (USD Million), 2018 & 2022 & 2029
Figure 3. Global Human Vaccine Consumption Value Market Share by Type in 2022
Figure 4. Varicella Examples
Figure 5. Influenza Examples
Figure 6. Polio Examples
Figure 7. Hepatitis A Examples
Figure 8. Rabies Examples
Figure 9. BCG Examples
Figure 10. Hepatitis B Examples
Figure 11. Pertussis, Diphtheria, Tetanus Examples
Figure 12. Pneumococcal Examples
Figure 13. Rota vaccine Examples
Figure 14. Global Human Vaccine Consumption Value by Application, (USD Million), 2018 & 2022 & 2029
Figure 15. Global Human Vaccine Consumption Value Market Share by Application in 2022
Figure 16. Adults Examples
Figure 17. Children Examples
Figure 18. Global Human Vaccine Consumption Value, (USD Million): 2018 & 2022 & 2029
Figure 19. Global Human Vaccine Consumption Value and Forecast (2018-2029) & (USD Million)
Figure 20. Global Human Vaccine Sales Quantity (2018-2029) & (M Doses)
Figure 21. Global Human Vaccine Average Price (2018-2029) & (USD/Dose)
Figure 22. Global Human Vaccine Sales Quantity Market Share by Manufacturer in 2022
Figure 23. Global Human Vaccine Consumption Value Market Share by Manufacturer in 2022
Figure 24. Producer Shipments of Human Vaccine by Manufacturer Sales Quantity ($MM) and Market Share (%): 2021
Figure 25. Top 3 Human Vaccine Manufacturer (Consumption Value) Market Share in 2022
Figure 26. Top 6 Human Vaccine Manufacturer (Consumption Value) Market Share in 2022
Figure 27. Global Human Vaccine Sales Quantity Market Share by Region (2018-2029)
Figure 28. Global Human Vaccine Consumption Value Market Share by Region (2018-2029)
Figure 29. North America Human Vaccine Consumption Value (2018-2029) & (USD Million)
Figure 30. Europe Human Vaccine Consumption Value (2018-2029) & (USD Million)
Figure 31. Asia-Pacific Human Vaccine Consumption Value (2018-2029) & (USD Million)
Figure 32. South America Human Vaccine Consumption Value (2018-2029) & (USD Million)
Figure 33. Middle East & Africa Human Vaccine Consumption Value (2018-2029) & (USD Million)
Figure 34. Global Human Vaccine Sales Quantity Market Share by Type (2018-2029)
Figure 35. Global Human Vaccine Consumption Value Market Share by Type (2018-2029)
Figure 36. Global Human Vaccine Average Price by Type (2018-2029) & (USD/Dose)
Figure 37. Global Human Vaccine Sales Quantity Market Share by Application (2018-2029)
Figure 38. Global Human Vaccine Consumption Value Market Share by Application (2018-2029)
Figure 39. Global Human Vaccine Average Price by Application (2018-2029) & (USD/Dose)
Figure 40. North America Human Vaccine Sales Quantity Market Share by Type (2018-2029)
Figure 41. North America Human Vaccine Sales Quantity Market Share by Application (2018-2029)
Figure 42. North America Human Vaccine Sales Quantity Market Share by Country (2018-2029)
Figure 43. North America Human Vaccine Consumption Value Market Share by Country (2018-2029)
Figure 44. United States Human Vaccine Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 45. Canada Human Vaccine Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 46. Mexico Human Vaccine Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 47. Europe Human Vaccine Sales Quantity Market Share by Type (2018-2029)
Figure 48. Europe Human Vaccine Sales Quantity Market Share by Application (2018-2029)
Figure 49. Europe Human Vaccine Sales Quantity Market Share by Country (2018-2029)
Figure 50. Europe Human Vaccine Consumption Value Market Share by Country (2018-2029)
Figure 51. Germany Human Vaccine Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 52. France Human Vaccine Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 53. United Kingdom Human Vaccine Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 54. Russia Human Vaccine Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 55. Italy Human Vaccine Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 56. Asia-Pacific Human Vaccine Sales Quantity Market Share by Type (2018-2029)
Figure 57. Asia-Pacific Human Vaccine Sales Quantity Market Share by Application (2018-2029)
Figure 58. Asia-Pacific Human Vaccine Sales Quantity Market Share by Region (2018-2029)
Figure 59. Asia-Pacific Human Vaccine Consumption Value Market Share by Region (2018-2029)
Figure 60. China Human Vaccine Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 61. Japan Human Vaccine Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 62. Korea Human Vaccine Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 63. India Human Vaccine Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 64. Southeast Asia Human Vaccine Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 65. Australia Human Vaccine Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 66. South America Human Vaccine Sales Quantity Market Share by Type (2018-2029)
Figure 67. South America Human Vaccine Sales Quantity Market Share by Application (2018-2029)
Figure 68. South America Human Vaccine Sales Quantity Market Share by Country (2018-2029)
Figure 69. South America Human Vaccine Consumption Value Market Share by Country (2018-2029)
Figure 70. Brazil Human Vaccine Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 71. Argentina Human Vaccine Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 72. Middle East & Africa Human Vaccine Sales Quantity Market Share by Type (2018-2029)
Figure 73. Middle East & Africa Human Vaccine Sales Quantity Market Share by Application (2018-2029)
Figure 74. Middle East & Africa Human Vaccine Sales Quantity Market Share by Region (2018-2029)
Figure 75. Middle East & Africa Human Vaccine Consumption Value Market Share by Region (2018-2029)
Figure 76. Turkey Human Vaccine Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 77. Egypt Human Vaccine Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 78. Saudi Arabia Human Vaccine Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 79. South Africa Human Vaccine Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 80. Human Vaccine Market Drivers
Figure 81. Human Vaccine Market Restraints
Figure 82. Human Vaccine Market Trends
Figure 83. Porters Five Forces Analysis
Figure 84. Manufacturing Cost Structure Analysis of Human Vaccine in 2022
Figure 85. Manufacturing Process Analysis of Human Vaccine
Figure 86. Human Vaccine Industrial Chain
Figure 87. Sales Quantity Channel: Direct to End-User vs Distributors
Figure 88. Direct Channel Pros & Cons
Figure 89. Indirect Channel Pros & Cons
Figure 90. Methodology
Figure 91. Research Process and Data Source
Please feel free to write an email to us or to use our electronic ticketing system.
